Singapore markets closed
Straits Times Index
3,293.13 +20.41 (+0.62%) S&P 500
5,064.61 -5.94 (-0.12%) Dow
38,368.56 -135.13 (-0.35%) Nasdaq
15,725.28 +28.64 (+0.18%) Bitcoin USD
64,941.10 -1,661.13 (-2.49%) CMC Crypto 200
1,402.39 -21.71 (-1.52%)
Edwards Lifesciences Corporation (EW)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 11:40AM EDT. Market open.
| Previous close | 87.75 |
| Open | 87.88 |
| Bid | 88.28 x 1100 |
| Ask | 88.33 x 800 |
| Day's range | 87.72 - 89.17 |
| 52-week range | 60.57 - 96.12 |
| Volume | |
| Avg. volume | 4,005,437 |
| Market cap | 53.219B |
| Beta (5Y monthly) | 1.07 |
| PE ratio (TTM) | 38.44 |
| EPS (TTM) | 2.30 |
| Earnings date | 25 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 94.52 |
ZacksOngoing Procedural Growth May Aid Stryker's (SYK) Q1 Earnings
Stryker's (SYK) first-quarter 2024 results are expected to reflect strong segmental performance. However, rising costs are likely to have continued to hurt margins.
ZacksDexCom (DXCM) to Report Q1 Earnings: What's in the Cards?
DexCom's (DXCM) first-quarter 2024 results are likely to reflect rising volumes across all channels.
ZacksIs a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings?
West Pharmaceutical's (WST) first-quarter 2024 results are likely to reflect strength in its Proprietary Products business. However, unfavorable currency movements might have hurt the top and bottom lines.
© 2024 Yahoo. All rights reserved.